Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
07/31/2023 | 24.93% | UBS | $155 → $188 | Maintains | Buy |
07/13/2023 | -4.31% | Goldman Sachs | $126 → $144 | Maintains | Neutral |
07/07/2023 | -6.31% | Wedbush | $137 → $141 | Maintains | Outperform |
06/01/2023 | 232.25% | Deutsche Bank | → $500 | Initiates Coverage On | → Buy |
05/02/2023 | -8.3% | Keefe, Bruyette & Woods | $125 → $138 | Maintains | Market Perform |
04/28/2023 | -6.97% | Credit Suisse | $130 → $140 | Maintains | Outperform |
04/27/2023 | -12.29% | Wedbush | → $132 | Reiterates | → Outperform |
04/12/2023 | -12.29% | Wedbush | → $132 | Reiterates | → Outperform |
03/06/2023 | -14.28% | JP Morgan | → $129 | Upgrades | Neutral → Overweight |
02/07/2023 | -14.28% | JP Morgan | $90 → $129 | Maintains | Neutral |
02/06/2023 | -15.61% | Keybanc | $104 → $127 | Maintains | Overweight |
02/03/2023 | -13.62% | Credit Suisse | $106 → $130 | Maintains | Outperform |
01/12/2023 | -31.56% | Goldman Sachs | $87 → $103 | Maintains | Neutral |
11/14/2022 | -36.21% | Keybanc | $87 → $96 | Maintains | Overweight |
10/12/2022 | -45.51% | Goldman Sachs | $93 → $82 | Maintains | Neutral |
10/10/2022 | -32.22% | Wedbush | $130 → $102 | Maintains | Outperform |
09/19/2022 | -42.19% | Keybanc | → $87 | Upgrades | Sector Weight → Overweight |
07/29/2022 | -20.26% | UBS | $110 → $120 | Maintains | Buy |
07/12/2022 | -39.53% | JP Morgan | $94 → $91 | Maintains | Neutral |
06/23/2022 | -44.85% | Goldman Sachs | $100 → $83 | Maintains | Neutral |
06/17/2022 | -56.81% | Wells Fargo | → $65 | Downgrades | Equal-Weight → Underweight |
06/16/2022 | -26.91% | UBS | $156 → $110 | Maintains | Buy |
05/13/2022 | — | Wolfe Research | Downgrades | Outperform → Peer Perform | |
05/04/2022 | -40.2% | Wells Fargo | $87 → $90 | Maintains | Equal-Weight |
04/29/2022 | -29.56% | Credit Suisse | $103 → $106 | Maintains | Outperform |
04/13/2022 | -40.86% | JP Morgan | $111 → $89 | Maintains | Neutral |
04/12/2022 | -38.87% | Goldman Sachs | $114 → $92 | Maintains | Neutral |
04/05/2022 | -31.56% | Credit Suisse | → $103 | Initiates Coverage On | → Outperform |
03/10/2022 | -26.24% | JP Morgan | $148 → $111 | Downgrades | Overweight → Neutral |
01/31/2022 | — | Keybanc | Downgrades | Overweight → Sector Weight | |
01/18/2022 | 4.33% | Wedbush | → $157 | Initiates Coverage On | → Outperform |
12/13/2021 | — | Zelman | Upgrades | Hold → Buy | |
10/29/2021 | -3.65% | Keybanc | $130 → $145 | Maintains | Overweight |
10/14/2021 | -4.98% | JP Morgan | $158 → $143 | Upgrades | Neutral → Overweight |
08/04/2021 | -13.62% | Wolfe Research | → $130 | Upgrades | Peer Perform → Outperform |
07/30/2021 | -13.62% | Keybanc | $120 → $130 | Maintains | Overweight |
06/30/2021 | -26.91% | Goldman Sachs | $117 → $110 | Maintains | Neutral |
04/19/2021 | -26.91% | Keybanc | $100 → $110 | Maintains | Overweight |
04/16/2021 | -33.55% | Wells Fargo | → $100 | Initiates Coverage On | → Equal-Weight |
03/16/2021 | — | Wolfe Research | Initiates Coverage On | → Peer Perform | |
02/22/2021 | -33.55% | Keybanc | → $100 | Initiates Coverage On | → Overweight |
02/02/2021 | -22.92% | JP Morgan | $123 → $116 | Maintains | Neutral |
01/29/2021 | -29.56% | Credit Suisse | $134 → $106 | Maintains | Outperform |
01/29/2021 | -31.56% | B of A Securities | $121 → $103 | Downgrades | Buy → Neutral |
01/29/2021 | — | BTIG | Downgrades | Buy → Neutral | |
01/22/2021 | — | Janney Montgomery Scott | Initiates Coverage On | → Neutral | |
10/23/2020 | -10.96% | Credit Suisse | $132 → $134 | Maintains | Outperform |
10/16/2020 | -10.29% | BTIG | $117 → $135 | Maintains | Buy |
10/08/2020 | -8.96% | JP Morgan | → $137 | Downgrades | Overweight → Neutral |
09/22/2020 | -8.3% | B of A Securities | $125 → $138 | Maintains | Buy |
09/21/2020 | -20.26% | Wells Fargo | → $120 | Upgrades | Equal-Weight → Overweight |
07/24/2020 | -24.91% | Credit Suisse | $96 → $113 | Maintains | Outperform |
07/24/2020 | -22.25% | BTIG | $109 → $117 | Maintains | Buy |
07/21/2020 | -27.57% | BTIG | → $109 | Upgrades | Neutral → Buy |
07/16/2020 | -46.84% | Goldman Sachs | $64 → $80 | Upgrades | Sell → Neutral |
06/11/2020 | -41.52% | JP Morgan | → $88 | Upgrades | Neutral → Overweight |
06/05/2020 | -48.83% | Evercore ISI Group | → $77 | Downgrades | Outperform → In-Line |
05/28/2020 | -46.18% | Credit Suisse | → $81 | Initiates Coverage On | → Outperform |
04/30/2020 | -63.45% | Wells Fargo | $40 → $55 | Maintains | Equal-Weight |
04/29/2020 | -56.81% | CFRA | $87 → $65 | Reiterates | → Strong Buy |
03/18/2020 | -74.75% | JP Morgan | $76 → $38 | Maintains | Neutral |
01/28/2020 | -48.83% | Evercore ISI Group | $67 → $77 | Upgrades | In-Line → Outperform |
12/06/2019 | -60.79% | Goldman Sachs | → $59 | Initiates Coverage On | → Sell |
10/24/2019 | -45.51% | Wells Fargo | $70 → $82 | Maintains | Market Perform |
09/18/2019 | -45.51% | B of A Securities | $79 → $82 | Maintains | Buy |
09/11/2019 | -55.15% | JP Morgan | $54.5 → $67.5 | Upgrades | Underweight → Neutral |
07/25/2019 | — | Citigroup | Upgrades | Neutral → Buy | |
03/07/2019 | — | JP Morgan | Downgrades | Neutral → Underweight | |
03/05/2019 | -74.08% | Wedbush | $41 → $39 | Maintains | Neutral |
02/01/2019 | — | JMP Securities | Downgrades | Outperform → Market Perform | |
02/01/2019 | — | Citigroup | Downgrades | Buy → Neutral | |
01/10/2019 | -72.76% | Wedbush | → $41 | Downgrades | Outperform → Neutral |
01/04/2019 | -70.1% | Citigroup | $47 → $45 | Maintains | Buy |
10/25/2018 | -71.43% | Evercore ISI Group | $47 → $43 | Upgrades | In-Line → Outperform |
10/22/2018 | — | Deutsche Bank | Upgrades | Hold → Buy | |
10/17/2018 | -76.08% | Credit Suisse | $50 → $36 | Downgrades | Outperform → Neutral |
10/11/2018 | -68.1% | JMP Securities | $58 → $48 | Maintains | Market Outperform |
09/21/2018 | -69.43% | JP Morgan | $55 → $46 | Downgrades | Overweight → Neutral |
What is the target price for Meritage Homes (MTH)?
The latest price target for Meritage Homes (NYSE: MTH) was reported by UBS on July 31, 2023. The analyst firm set a price target for $188.00 expecting MTH to rise to within 12 months (a possible 24.93% upside). 17 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Meritage Homes (MTH)?
The latest analyst rating for Meritage Homes (NYSE: MTH) was provided by UBS, and Meritage Homes maintained their buy rating.
When is the next analyst rating going to be posted or updated for Meritage Homes (MTH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Meritage Homes, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Meritage Homes was filed on July 31, 2023 so you should expect the next rating to be made available sometime around July 31, 2024.
Is the Analyst Rating Meritage Homes (MTH) correct?
While ratings are subjective and will change, the latest Meritage Homes (MTH) rating was a maintained with a price target of $155.00 to $188.00. The current price Meritage Homes (MTH) is trading at is $150.49, which is out of the analyst's predicted range.